Reilly Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $588K | Sell |
4,341
-332
| -7% | -$39.2K | 0.04% | 146 |
|
|
2021
Q3 | $504K | Sell |
4,673
-157
| -3% | -$17.9K | 0.04% | 142 |
|
|
2021
Q2 | $544K | Buy |
4,830
+345
| +8% | +$38.9K | 0.04% | 144 |
|
|
2021
Q1 | $485K | Buy |
4,485
+475
| +12% | +$50.8K | 0.04% | 139 |
|
|
2020
Q4 | $430K | Buy |
4,010
+623
| +18% | +$59.9K | 0.04% | 142 |
|
|
2020
Q3 | $297K | Hold |
3,387
| – | – | 0.03% | 149 |
|
|
2020
Q2 | $333K | Buy |
3,387
+1,155
| +52% | +$102K | 0.04% | 146 |
|
|
2020
Q1 | $170K | Buy |
2,232
+413
| +23% | +$35.2K | 0.02% | 176 |
|
|
2019
Q4 | $161K | Sell |
1,819
-867
| -32% | -$72K | 0.02% | 202 |
|
|
2019
Q3 | $203K | Buy |
2,686
+164
| +7% | +$11.2K | 0.02% | 183 |
|
|
2019
Q2 | $183K | Sell |
2,522
-15
| -0.6% | -$1.18K | 0.02% | 187 |
|
|
2019
Q1 | $204K | Sell |
2,537
-55
| -2% | -$4.5K | 0.03% | 169 |
|
|
2018
Q4 | $239K | Sell |
2,592
-713
| -22% | -$62.7K | 0.03% | 159 |
|
|
2018
Q3 | $313K | Hold |
3,305
| – | – | 0.04% | 147 |
|
|
2018
Q2 | $306K | Hold |
3,305
| – | – | 0.04% | 141 |
|
|
2018
Q1 | $313K | Buy |
3,305
+10
| +0.3% | +$1.1K | 0.04% | 138 |
|
|
2017
Q4 | $319K | Sell |
3,295
-153
| -4% | -$14.4K | 0.05% | 139 |
|
|
2017
Q3 | $306K | Hold |
3,448
| – | – | 0.05% | 129 |
|
|
2017
Q2 | $250K | Hold |
3,448
| – | – | 0.04% | 142 |
|
|
2017
Q1 | $225K | Buy |
3,448
+485
| +16% | +$30.5K | 0.04% | 143 |
|
|
2016
Q4 | $186K | Buy |
2,963
+314
| +12% | +$19.2K | 0.03% | 151 |
|
|
2016
Q3 | $167K | Sell |
2,649
-420
| -14% | -$27.2K | 0.03% | 152 |
|
|
2016
Q2 | $190K | Buy |
3,069
+281
| +10% | +$17.1K | 0.03% | 141 |
|
|
2016
Q1 | $159K | Sell |
2,788
-50
| -2% | -$2.79K | 0.03% | 206 |
|
|
2015
Q4 | $168K | Sell |
2,838
-839
| -23% | -$48.3K | 0.03% | 198 |
|
|
2015
Q3 | $200K | Buy |
3,677
+27
| +0.7% | +$1.76K | 0.04% | 173 |
|
|
2015
Q2 | $245K | Sell |
3,650
-377
| -9% | -$24.6K | 0.04% | 170 |
|
|
2015
Q1 | $236K | Sell |
4,027
-100
| -2% | -$6.04K | 0.04% | 160 |
|
|
2014
Q4 | $270K | Buy |
4,127
+961
| +30% | +$60.6K | 0.06% | 120 |
|
|
2014
Q3 | $183K | Buy |
3,166
+197
| +7% | +$10.9K | 0.04% | 131 |
|
|
2014
Q2 | $169K | Buy |
2,969
+500
| +20% | +$26.2K | 0.04% | 130 |
|
|
2014
Q1 | $127K | Buy |
2,469
+113
| +5% | +$5.71K | 0.03% | 155 |
|
|
2013
Q4 | $124K | Buy |
2,356
+940
| +66% | +$46.2K | 0.03% | 143 |
|
|
2013
Q3 | $65K | Sell |
1,416
-97
| -6% | -$4.3K | 0.02% | 184 |
|
|
2013
Q2 | $64K | Buy |
+1,513
| New | +$66.2K | 0.02% | 177 |
|
Other funds holding ABBV
Reilly Financial Advisors's ABBV Position: Q4 2021 in Review
Reilly Financial Advisors reduced its AbbVie (ABBV) stake by 7.1% in Q4 2021, selling an estimated $39.2K and leaving 4,341 shares worth $588K. The position accounts for 0.04% of the portfolio, ranked #146.
Reilly Financial Advisors first reported a position in ABBV in Q2 2013 and has held it in 35 quarters since. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- Reilly Financial Advisors held 4,341 shares of AbbVie worth $588K as of Q4 2021.
- Reilly Financial Advisors sold 332 AbbVie shares in Q4 2021, an estimated $39.2K.
- AbbVie made up 0.04% of Reilly Financial Advisors's portfolio in Q4 2021, its #146 holding.
- Reilly Financial Advisors first reported a position in AbbVie in Q2 2013 and has held it in 35 quarters since.
- 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.